SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Generic take-up in the pharmaceutical market following patent expiry
10 references·2 citing·40 second hop
Generic take-up in the pharmaceutical market following patent expiry (2000)Generic take-up in the pharmaceutical mar…How Valuable is Patent Protection? Estimates by Technology Field (1998)How Valuable is Patent Protec…Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins (1997)Characteristics of Demand for…Longer Patents for Increased Generic Competition in the US (1996)Longer Patents for Increased …Estimates of the Value of Patent Rights in Great Britain and Ireland, 1852- 1876 (1994)Estimates of the Value of Pat…Generics and New Goods in Pharmaceutical Price Indexes (1993)Generics and New Goods in Pha…Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Brand Loyalty, Entry, and Pri…Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Patent Expiration, Entry, and…Optimal Patent Length and Breadth (1990)Optimal Patent Length and Bre…Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals (1988)Persuasion or Information? Pr…"Innovation in the Pharmaceutical Industry". (1978)"Innovation in the Pharmaceut…Location choice and the internationalization sequence (2011)Location choice and the inter…Dynamic competition in pharmaceuticals (2004)Dynamic competition in pharma…Econometric Measurement of the Duration of Advertising Effect on Sales (1976)Optimal Advertising and Optimal Quality (1976)Product differentiation advantages of pioneering brands (1980)Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry (2000)Do Pharmaceutical Sales Respond to Scientific Evidence? (2002)Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration (2011)Industrial Market Structure and Economic Performance. (1971)Generic Entry and the Pricing of Pharmaceuticals (1997)Uncertainty and Learning in Pharmaceutical Demand (2005)Killer Acquisitions (2020)Economics and Consumer Behavior (1980)Discrete Choice Theory of Product Differentiation (1992)Product Differentiation and Oligopoly in International Markets: The Case of the U.S. Automobile Industry (1995)The Pharmaceutical Industry (2013)Empirical studies of innovation and market structure (1989)Dynamic count data models of technological innovation (1994)Determinants of branded prescription medicine prices in OECD countries (2011)Does the Market Share of Generic Medicines Influence the Price Level? (2011)Cost of innovation in the pharmaceutical industry (1991)Price Competition in Pharmaceuticals: The Case of Anti‐infectives (2004)Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States (2016)Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry (2016)MONOPOLISTIC COMPETITION AND OPTIMUM PRODUCT DIVERSITY (1975)Relaxing Price Competition Through Product Differentiation (1982)Empirical patterns of firm growth and R&D investment: a quality ladder model interpretation (1999)Generic entry, price competition, and market segmentation in the prescription drug market (2007)A DYNAMIC OLIGOPOLY STRUCTURAL MODEL FOR THE PRESCRIPTION DRUG MARKET AFTER PATENT EXPIRATION* (2010)Free Entry and Social Inefficiency (1986)Estimation of a Model of Entry in the Airline Industry (1992)Automobile Prices in Market Equilibrium (1995)Generic Drug Industry Dynamics (2005)Pharmaceutical Price Controls and Entry Strategies (2007)Against Intellectual Monopoly (2008)Fifty Years of Empirical Studies of Innovative Activity and Performance (2010)On the green and innovative side of trade competitiveness? The impact of environmental policies and innovation on EU exports (2011)The political economy of the pharmaceutical industry. (1986)Moral hazard in physician prescription behavior (2000)Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality (2004)On the Division of Profit in Sequential Innovation (1995)How Do Patent Laws Influence Innovation? Evidence from Nineteenth-Century World's Fairs (2005)
this work references cited by second hop

References

  • 1990Optimal Patent Length and Breadth847 cited
  • 1992Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act574 cited
  • 1998How Valuable is Patent Protection? Estimates by Technology Field461 cited
  • 1991Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry399 cited
  • 1988Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals254 cited
  • 1997Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins230 cited
  • 1978"Innovation in the Pharmaceutical Industry".194 cited
  • 1993Generics and New Goods in Pharmaceutical Price Indexes179 cited
  • 1996Longer Patents for Increased Generic Competition in the US136 cited
  • 1994Estimates of the Value of Patent Rights in Great Britain and Ireland, 1852- 187660 cited

Cited by

  • 2004Dynamic competition in pharmaceuticals85 cited
  • 2011Location choice and the internationalization sequence43 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work